Indoleamine 2,3-dioxygenase-1 (IDO1) plays an important role in tumor immune escape. However, unsatisfactory clinical efficacies of selective IDO1 inhibitors have impeded their further development, su
MYBL2 has been demonstrated to be an oncogene in some cancers, but there is no pan-cancer analysis at the macro level. We used multiple online or offline bioinformatic tools to examine the effects of
Dataset used for the statistical analysis of the data to be published in a paper entitled "BONE DAMAGE AFTER CHEMOTHERAPY FOR LYMPHOMA: A REAL-WORLD EXPERIENCE"
